No Picture
News

Cytokinetics’ ALS drug fails PhIII, leaving the biotech with a single late-stage prospect

Cytokinetics’ candidate for the muscle disease amyotrophic lateral sclerosis, or ALS, failed a Phase III trial, the Bay Area biotech announced Friday morning. At a second interim analysis of the trial, an independent review committee recommended that C… […]

No Picture
News

Galapagos sends some employees — and a research unit — off to drug discovery CRO as part of reorg

Paul Stoffels has made it clear that he views cutting jobs at Galapagos as difficult but necessary — but he’s getting creative about it. Galapagos, headquartered in Mechelen, Belgium, has struck an arrangement with French contract research organization… […]

No Picture
News

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., March 31, 2023 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on March 30, 2023, the… […]

No Picture
News

OmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

EMERYVILLE, Calif.–(BUSINESS WIRE)–OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2022, and provided operating and partner program updates. “Following the closing of the spin-off and busine… […]

No Picture
News

Lam Research Corporation Announces March 2023 Quarter Financial Conference Call

FREMONT, Calif., March 30, 2023 /PRNewswire/ — Lam Research Corp. (NASDAQ: LRCX) today announced that the company will host its quarterly financial conference call and webcast on Wednesday, April 19, 2023, beginning at 2:00 p.m. Pacific Time (5:00 p.m… […]

No Picture
News

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights

DAVIS, Calif.–(BUSINESS WIRE)–Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2022. … […]